Retatrutide / 10 mg

Retatrutide is a novel triple receptor agonist under active investigation for metabolic research. Each vial contains 10 mg of lyophilised peptide, third-party verified by HPLC and mass spectrometry. Certificate of Analysis included with every batch.

By purchasing, you confirm you are a qualified researcher and that this product will only be used for in-vitro laboratory research. Not for human or veterinary use.